These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 9343394

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.
    Sato H, Seiki M.
    Oncogene; 1993 Feb; 8(2):395-405. PubMed ID: 8426746
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells.
    Harendza S, Pollock AS, Mertens PR, Lovett DH.
    J Biol Chem; 1995 Aug 11; 270(32):18786-96. PubMed ID: 7642529
    [Abstract] [Full Text] [Related]

  • 25. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P.
    J Cell Biol; 1997 Apr 07; 137(1):67-77. PubMed ID: 9105037
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.
    Li J, Tan M, Li L, Pamarthy D, Lawrence TS, Sun Y.
    Neoplasia; 2005 Apr 07; 7(4):312-23. PubMed ID: 15967108
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
    Stearns ME, Kim G, Garcia F, Wang M.
    Mol Cancer Res; 2004 Jul 07; 2(7):403-16. PubMed ID: 15280448
    [Abstract] [Full Text] [Related]

  • 31. Monocytic cell type-specific transcriptional induction of collagenase.
    Pierce RA, Sandefur S, Doyle GA, Welgus HG.
    J Clin Invest; 1996 Apr 15; 97(8):1890-9. PubMed ID: 8621773
    [Abstract] [Full Text] [Related]

  • 32. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
    Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ.
    Oncogene; 1997 Apr 24; 14(16):1995-8. PubMed ID: 9150367
    [Abstract] [Full Text] [Related]

  • 33. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13).
    Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD, Howell DS, Cheung HS.
    J Biol Chem; 2000 Apr 14; 275(15):11327-32. PubMed ID: 10753945
    [Abstract] [Full Text] [Related]

  • 34. Oncogenes control stromelysin and collagenase gene expression.
    Butticé G, Kurkinen M.
    Contrib Nephrol; 1994 Apr 14; 107():101-7. PubMed ID: 8004955
    [No Abstract] [Full Text] [Related]

  • 35. Transcriptional activation of the human S100A2 promoter by wild-type p53.
    Tan M, Heizmann CW, Guan K, Schafer BW, Sun Y.
    FEBS Lett; 1999 Feb 26; 445(2-3):265-8. PubMed ID: 10094469
    [Abstract] [Full Text] [Related]

  • 36. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts.
    Wucherpfennig AL, Li YP, Stetler-Stevenson WG, Rosenberg AE, Stashenko P.
    J Bone Miner Res; 1994 Apr 26; 9(4):549-56. PubMed ID: 8030443
    [Abstract] [Full Text] [Related]

  • 37. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines.
    Sehgal I, Thompson TC.
    Cancer Res; 1998 Oct 01; 58(19):4288-91. PubMed ID: 9766654
    [Abstract] [Full Text] [Related]

  • 38. v-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors.
    Vincenti MP, Schroen DJ, Coon CI, Brinckerhoff CE.
    Mol Carcinog; 1998 Mar 01; 21(3):194-204. PubMed ID: 9537651
    [Abstract] [Full Text] [Related]

  • 39. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C, Pazzaglia L, Conti A, Quattrini I, Pollino S, Perego P, Picci P, Benassi MS.
    PLoS One; 2014 Mar 01; 9(12):e114757. PubMed ID: 25490093
    [Abstract] [Full Text] [Related]

  • 40. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
    Takeshita H, Yoshizaki T, Miller WE, Sato H, Furukawa M, Pagano JS, Raab-Traub N.
    J Virol; 1999 Jul 01; 73(7):5548-55. PubMed ID: 10364303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.